🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🏆Our CEO and Founder Dr. Nicole Paulk has been named to the 2025 Women to Watch list by the San Francisco Business Times! Hear about her experience founding Siren Biotechnology, Inc. and lessons learned along the way at the link below. Congratulations, Nicole! bizjournals.com/sanfrancisco/n… #leadership #biotech

Catch us on @BiotechTVHQ discussing Siren Biotechnology, Inc.’s community #investment round! Learn more and invest in the future of #GeneTherapy and #Cancer here: wefunder.com/siren.biotechn… Thanks for coming by, Brad Loncar!

The Siren Biotechnology, Inc. team is headed to #ASGCT2025 in just 1 month! 🎉 We’ve got an exciting lineup highlighting our latest data and we can’t wait to connect with fellow innovators in #GeneTherapy! Find us at the events below — see you in New Orleans! 👋 #AAV #GeneTherapy #Innovation

Join Siren Biotechnology, Inc.'s CEO and Founder Dr. Nicole Paulk this Thursday at Capital Connect: Rising Above the Noise in Biopharma Investing, hosted by Foley & Lardner LLP, CollectiveMinds LLC, and HSBC. See you there! Event Website: lnkd.in/dVg6bKSJ Registration: lnkd.in/dCApDdt5

A great feature on Siren Biotechnology, Inc.'s community investment round in BioPharma Dive by Gwendolyn Wu! Interested in #investing? Join here! wefunder.com/siren.biotechn…

Yesterday, Siren Biotechnology, Inc.'s CEO and Founder Dr. Nicole Paulk held a lively discussion with the MBC BioLabs startup community about our experience interacting with the #FDA for our SRN-101 #preIND as well as our open Community #Investment Round! Interested in investing? Join here!

Headed to #ASGCT2025 next week? The Siren Biotechnology, Inc. team will be there with new data and new sock swag! That’s right folks, if you thought last year’s cat socks were winners, just wait till you see this year’s design! 🧦 Find us at any of the events below to snag some for yourself and

Do you like oysters, great company, and discussing the latest developments in #AAV #GeneTherapy? Join the Siren Biotechnology, Inc. team at our #ASGCT2025 happy hour on Thursday May 15! RSVP below 🦪🍹 lu.ma/0ybev9li

The Siren Biotechnology, Inc. team is on our way to #ASGCT2025! Find us tomorrow at posters #713 and #1199 (5:30 - 7:00pm) and ask a question about our science for your own pair of New Orleans-themed Siren cat socks 😻! Full list of Siren events below: Tues 13th: AAV Vector Manufacturing:

Hey #ASGCT2025 career seekers! 👋 Siren Biotechnology, Inc. is excited to support the next generation of #GeneTherapy talent — starting with you! Stop by our ASGCT Career Fair booth for a personalized resume or LinkedIn profile review. Whether you're job hunting or just curious, we’re here to

Siren Biotechnology, Inc.'s Preclinical Team is showcasing our latest progress in 2 posters at #ASGCT2025! Find us this evening at posters #713 and #1199 to learn about how we’re changing the game with #AAV Immuno #GeneTherapy for #Cancer. Congratulations to lead authors Chris Lovejoy and Tian

Close out #ASGCT2025 with Siren Biotechnology, Inc.’s Founder and CEO Dr. Nicole Paulk tomorrow morning! We’ll be talking about the foundational principals behind Siren and what it’s like to bring #AAV #GeneTherapy into the #oncology space. Saturday, May 17 | 9:15am | RM 293-296 See you

The Siren Biotechnology, Inc. team had quite the week at #ASGCT2025 in New Orleans! Our days were full of great science, meaningful conversations, and New Orleans magic. Highlights included: 📣 Seeing Dr. Nicole Paulk present on our Universal #AAV Immuno-Gene Therapy platform 🔬 Presenting two

🚨 ATTN Siren Biotechnology, Inc.'s community round is officially OPEN to the public! We’ve raised $28M+ from top VCs. Now, we’re opening the doors to everyone because the future of cancer care should belong to all of us. Invest now: wefunder.com/sirenbiotechno… #Investing #Biotech #Cancer #AAV

As #GrayMay comes to an end, we're grounded in our mission at Siren Biotechnology, Inc. to bring better treatments to patients who can’t wait. We’re working to bring SRN-101, our lead asset for high-grade glioma, to patients as quickly and safely as possible. Every step forward is motivated by

As #GrayMay comes to an end, we're grounded in our mission at Siren Biotechnology, Inc. to bring better treatments to patients who can’t wait. We’re working to bring SRN-101, our lead asset for high-grade glioma, to patients as quickly and safely as possible. Every step forward is motivated by

Catch Siren Biotechnology, Inc.'s CEO Dr. Nicole Paulk on Superpowers 4 Good to hear about the science and mission that made our Community Investment Round the #1 raised in the nation last month! superpowers4good.com/p/transforming…